Xconomy Boston

ACT Creates Stem Cells, Spares Embryos

Henry Johnson1/10/08

Advanced Cell Technology, a Los Angeles, CA-based stem cell company with research operations in Worcester, MA, announced on Thursday that it’s been able to derive five stem cell lines from human embryos without destroying the embryos. The company’s approach (OTC BB: ACTC) was published in the new edition of the journal Cell Stem Cells, published by Cell Press. Scientists in Japan and at the Harvard Stem Cell Institute recently used a different technique—starting with adult cells rather than embryonic ones—to produce similar cell lines.

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.